AppealFlow.net

Experimental or Investigational Denial: What to Do

By AppealFlow editorial•12 min read••
Experimental or investigational insurance denial appeal workflow showing FDA labeling, clinical trial data, and appeal letter documents
An experimental or investigational denial means the plan is refusing coverage because it classifies the drug, device, or procedure as unproven under the policy, not because your clinician was wrong to recommend the care. Healthcare.gov lists experimental or investigative treatment as a denial you can internally appeal, and the same federal rules allow external review when the plan upholds an experimental or investigational determination. Request the denial letter and the plan's experimental definition, then file an appeal that answers that definition with FDA labeling for your indication, clinical trial data, or off-label evidence where the plan's policy permits it.

What the Plan Means by Experimental or Investigational

Key Takeaway: The letter is a coverage interpretation under the policy's experimental definition. Pull that definition from the certificate or Evidence of Coverage and answer it line by line. Do not argue a different denial reason than the one printed.

Commercial and Marketplace policies often exclude items they call experimental, investigational, unproven, or not standard of care. The definition may turn on FDA status, published trials, society guidelines, or whether the service is offered only under a research protocol. Two plans can classify the same CPT or drug differently. The controlling text is the booklet that applies to your group or individual contract, not a blog summary and not another insurer's medical policy.

Healthcare.gov's internal-appeals page lists “experimental” or “investigative” treatment among the denials you can internally appeal. File using the forms on the notice, or write with your name, claim number, and member ID, and attach the clinician letter and studies you want considered.

How Is This Different From a Medical-Necessity Denial?

Key Takeaway: Medical necessity asks whether this service is needed for your condition under the plan's clinical criteria. An experimental exclusion asks whether the service itself is covered at all. Mixing the two arguments without quoting the exclusion language is a common miss.

Denial on the letterWhat the plan is decidingWhat the packet should answer
Experimental / investigationalThe item is excluded as unproven, even if you have the diagnosisThe plan's own definition, FDA status for your indication, guidelines, and why this is standard care rather than a trial protocol
Not medically necessaryThe item may be a covered benefit, but the plan says it is not needed for youClinical criteria, failed conservative care, and a letter of medical necessity. See medical-necessity denials.
Both reasons on one noticeTwo separate coverage theoriesAnswer each heading. Do not treat an experimental cite as a typo for medical necessity.

Can I Appeal an Experimental Denial?

Key Takeaway: Yes, on commercial and Marketplace plans that follow the Healthcare.gov internal-appeal list. If the plan upholds the denial, Healthcare.gov treats experimental or investigational determinations as a type of denial that can go to external review.

File the internal appeal named on the notice within the deadline printed there. Filing windows differ by program. See how long you have to appeal a health insurance denial. Healthcare.gov's external-review page states that types of denials that can go to external review include any denial that involves medical judgment and any denial that involves a determination that a treatment is experimental or investigational. The same page says you generally file the written external-review request within 4 months after the insurer's notice or final determination. The walkthrough is in how to request external review after an insurance denial.

Medicare, Medicaid, and some grandfathered or excepted plans use other tracks. Do not assume ACA external review applies to every card in your wallet.

What Clinical Trial Data Should You Attach?

Key Takeaway: Many experimental definitions turn on whether the service is offered only under a research protocol or lacks published evidence. If you are not in a trial, attach peer-reviewed studies and guidelines that show standard-of-care use. If you are in a trial, say so and attach the protocol information the plan or Medicare needs to analyze routine-care costs.

Read the plan's experimental definition first. Some policies exclude anything “provided as part of a clinical trial” but cover the same drug outside a trial when FDA-approved and medically necessary. Others exclude services until a certain number of trials or years of use exist. Your appeal should map each element of that definition to facts in the record.

  • Not enrolled in a trial: Attach peer-reviewed studies your clinician cites, society guidelines, and a letter explaining why this is established care rather than research for your diagnosis.
  • Enrolled in a trial: State the trial name, sponsor, and whether the denied charge is for the investigational item or routine care related to the trial. Medicare and many commercial policies treat those categories differently.
  • Compassionate use or expanded access: If FDA allowed access outside a standard label, attach the authorization letter and explain how that fits the plan's experimental definition.

Do not dump every PubMed abstract you can find. Choose studies that match your diagnosis, dose, and line of therapy, and have your clinician explain in plain language why they rely on them.

What If the Drug Is FDA-Approved but Your Use Is Off-Label?

Key Takeaway: FDA approval for one indication is evidence the product is not an unapproved experiment for that labeled use. Off-label prescribing is common and legal, but coverage is a separate contract question. Quote the plan's off-label and experimental clauses and answer them with the clinician's rationale and published evidence.

When the labeled indication matches your diagnosis, attach the FDA prescribing information and say so directly. That is often the strongest response to an experimental exclusion for an approved drug or device. When your use is off-label, the appeal is about whether the plan's policy allows off-label coverage at all, and whether your record meets any off-label criteria the plan lists.

Your situationWhat to emphasize in the appeal
On-label use, experimental denial anywayFDA labeling for your indication, plan definition quote, and why the service is not a trial-only protocol
Off-label use, plan has an off-label clauseQuote the off-label clause, attach studies and clinician letter, and show failed on-label options if the policy requires them
Off-label use, plan excludes all off-label drugsThe exclusion language itself. Some plans allow exceptions when no on-label alternative exists. Check the certificate before arguing medical necessity alone.

Never claim FDA approval for an indication that does not exist on the label. Reviewers check. If the approved indication does not match, pivot to off-label evidence and the plan's own off-label rules.

Need a Draft That Answers the Exclusion?

AppealFlow drafts a medical necessity appeal letter from the denial reason and facts you enter. Quote the experimental definition from your booklet in the draft. You still file on the plan's portal or mail address.

Draft Medical Necessity Letter

Weak vs. Strong Language on an Experimental Denial

Key Takeaway: Quote the plan's experimental definition, the indication, and the evidence that matches that definition. “My doctor says this is standard” without the policy text leaves the examiner nothing to apply.

❌ Weak Request✓ Strong Request
“This is not experimental. Please approve it.”“Denial dated [date], claim #[number], reason: experimental/investigational. Certificate section [X] defines experimental as [quote]. [Drug/device/procedure] is FDA-[approved/cleared] for [indication] matching diagnosis [ICD-10]. Attached: labeling, [guideline], clinician letter mapping failed alternatives. Please reverse the exclusion and process under the covered-benefit and medical-necessity rules that remain.”
“The FDA approved it, so you have to pay.”“FDA status is submitted as evidence that this is not an unapproved experiment for the labeled indication. Coverage still follows the plan's experimental definition and remaining criteria. If the plan's objection is off-label use, the cited definition and off-label clause are [quote]; the clinician letter addresses that clause.”
“Medicare covers this under my employer's experimental clause.”“This is a Medicare [Advantage / Original] notice. Coverage follows the applicable NCD/LCD or Medicare Advantage organization determination, not the employer plan's experimental exclusion. I am filing the Medicare process on the notice dated [date].”

What Documents Belong in the Appeal Packet?

Key Takeaway: Start with the denial letter and the experimental definition from your certificate. Add FDA labeling when it matches your indication, clinical trial or study citations your clinician relies on, and a treating provider letter that maps each policy element to your chart.

  • Denial letter plus the experimental/investigational definition from the certificate or EOC
  • FDA labeling or clearance for the indication you actually have, if it exists
  • Peer-reviewed studies, society guidelines, and trial protocol information when relevant
  • Clinician letter mapping diagnosis, failed alternatives, and why this is standard care rather than a research-only protocol
  • Prior authorization history, if the plan previously approved related care

What If I Have Medicare Instead?

Key Takeaway: Original Medicare coverage follows statute, National Coverage Determinations, Local Coverage Determinations, and Medicare manuals, not your employer's experimental clause. Do not paste a commercial experimental argument into a Medicare redetermination.

CMS describes the Medicare coverage determination process: coverage is limited to items and services that are reasonable and necessary for the diagnosis or treatment of an illness or injury and within a Medicare benefit category. National coverage determinations are made through an evidence-based process. Where there is no national policy, a Medicare contractor may cover or deny under a local coverage determination. Search those documents in the Medicare Coverage Database. Medicare Advantage must cover what Original Medicare covers, with plan rules on top. Medicaid follows the state plan and, for managed care, the handbook.

Do not mix the tracks. A commercial experimental exclusion is a contract clause you appeal under Healthcare.gov internal appeal and, if eligible, external review. An NCD or LCD is a Medicare coverage rule you appeal through the Medicare notice. Filing the wrong letter on the wrong program wastes the deadline.

Frequently Asked Questions

What an experimental or investigational denial means, how it differs from medical necessity, and what to attach on commercial versus Medicare tracks.

Generate a Free Medical Necessity Appeal Draft

AppealFlow drafts a letter from the denial reason and facts you enter. Quote the experimental definition, attach clinical trial data or off-label evidence, and export PDF or Word. No account required.

  • 100% Free
  • No Signup
  • PDF & Word Export

Disclaimer: This article is for educational purposes only and does not constitute medical, legal, or financial advice. AppealFlow.net is not a healthcare provider, insurance broker, or law firm. Experimental exclusions, Medicare NCDs/LCDs, and Medicaid rules differ. Verify your certificate, denial notice, Healthcare.gov, CMS, or Medicare.gov before you file. For medical emergencies, call 911. See our full disclaimer.